Eighty-four percent of vaccine advisers to the U.S. Food and Drug Administration (FDA) voted Friday against a measure that would support booster shots in those ages 16 years and older. However, the panel unanimously voted in support of boosters for those 65 and over and at high risk.
Read more at:
https://www.nj.com/coronavirus/2021/09/84-of-fda-vaccine-advisers-vote-no-on-pfizer-vaccine-boosters.html
